HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Massimo Federico Selected Research

Neoplasms (Cancer)

1/2021ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project.
5/2020Advances in Treatment of Follicular Lymphoma.
1/2020Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials.
1/2018Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study.
10/2017Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials.
6/2017Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.
1/2017Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study.
10/2016Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies.
9/2015Twenty-years experience with de novo metastatic breast cancer.
9/2015Dismal outcome of T-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer Registry.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Massimo Federico Research Topics

Disease

32Neoplasms (Cancer)
01/2021 - 02/2002
24Hodgkin Disease (Hodgkin's Disease)
06/2016 - 06/2003
20Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022 - 11/2003
15Lymphoma (Lymphomas)
12/2019 - 02/2007
14Breast Neoplasms (Breast Cancer)
12/2015 - 03/2007
12Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2019 - 09/2002
9Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2022 - 01/2012
9Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2018 - 06/2005
7Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
11/2022 - 01/2012
6B-Cell Lymphoma (Lymphoma, B Cell)
11/2021 - 12/2002
5T-Cell Lymphoma (Lymphoma, T Cell)
11/2021 - 09/2015
5Ovarian Neoplasms (Ovarian Cancer)
01/2017 - 10/2006
4Second Primary Neoplasms (Neoplasms, Second)
04/2016 - 02/2002
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
07/2014 - 08/2010
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2021 - 02/2012
3Disease Progression
01/2015 - 07/2007
3Multiple Myeloma
10/2013 - 06/2003
2Pathologic Complete Response
11/2022 - 01/2013
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2017 - 06/2005
2Cardiotoxicity
01/2015 - 10/2011
2Infertility (Sterility)
06/2013 - 01/2012
1Prostatic Neoplasms (Prostate Cancer)
03/2021
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2017
1Fallopian Tube Neoplasms
01/2017
1Febrile Neutropenia
12/2016
1Familial Breast Cancer
09/2015
1Carcinogenesis
02/2015
1Sepsis (Septicemia)
01/2015
1Pneumonia (Pneumonitis)
01/2015
1Lymphopenia (Lymphocytopenia)
10/2014
1Colorectal Neoplasms (Colorectal Cancer)
11/2013

Drug/Important Bio-Agent (IBA)

23Rituximab (Mabthera)FDA Link
01/2022 - 07/2007
17Doxorubicin (Adriamycin)FDA LinkGeneric
12/2019 - 12/2005
14Prednisone (Sone)FDA LinkGeneric
12/2019 - 09/2002
14Vinblastine (Vinblastine Sulfate)FDA Link
06/2017 - 12/2003
14Bleomycin (Blenoxane)FDA LinkGeneric
06/2017 - 09/2002
13Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2019 - 09/2002
13Vincristine (Oncovin)FDA LinkGeneric
12/2019 - 09/2002
11AnthracyclinesIBA
01/2015 - 11/2003
9Dacarbazine (DIC)FDA LinkGeneric
06/2017 - 12/2005
8Biomarkers (Surrogate Marker)IBA
01/2018 - 11/2009
7Procarbazine (Matulane)FDA Link
04/2016 - 12/2005
6Methotrexate (Mexate)FDA LinkGeneric
11/2021 - 12/2003
5Vindesine (Vindesin)IBA
04/2016 - 12/2005
5Etoposide (VP 16)FDA LinkGeneric
04/2016 - 12/2005
5Lomustine (CCNU)FDA Link
04/2016 - 12/2005
4Cytarabine (Cytosar-U)FDA LinkGeneric
11/2021 - 02/2012
4liposomal doxorubicin (Doxil)FDA Link
02/2018 - 10/2011
4fludarabineIBA
01/2018 - 07/2007
3Anaplastic Lymphoma KinaseIBA
01/2021 - 01/2012
3Proteins (Proteins, Gene)FDA Link
04/2013 - 11/2009
3Estrogen ReceptorsIBA
01/2013 - 03/2012
3Biological ProductsIBA
01/2012 - 10/2009
3Mechlorethamine (Nitrogen Mustard)FDA Link
11/2011 - 12/2005
2Mitoxantrone (Novantrone)FDA LinkGeneric
01/2018 - 04/2015
2Melphalan (Alkeran)FDA LinkGeneric
04/2016 - 02/2009
2Brentuximab VedotinIBA
04/2016 - 09/2015
2Trastuzumab (Herceptin)FDA Link
09/2015 - 11/2012
2GemcitabineFDA Link
11/2014 - 03/2006
2Cisplatin (Platino)FDA LinkGeneric
11/2014 - 10/2006
2Dexamethasone (Maxidex)FDA LinkGeneric
11/2014 - 10/2011
2Estrogens (Estrogen)FDA Link
09/2013 - 01/2012
2Phenobarbital (Luminal)FDA Link
09/2013 - 11/2012
2Epirubicin (Ellence)FDA LinkGeneric
04/2012 - 04/2003
2Glutathione Transferase (Glutathione S-Transferase)IBA
03/2012 - 08/2011
1Codon (Codons)IBA
03/2021
1Bendamustine HydrochlorideFDA Link
12/2018
1RacivirIBA
01/2017
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2016
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2016
1Dihydrotachysterol (AT 10)IBA
04/2016
1human ERBB2 proteinIBA
12/2015
1Nonsense Codon (Nonsense Mutation)IBA
09/2015
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
09/2015
1Aromatase InhibitorsIBA
09/2015
1Hormones (Hormone)IBA
09/2015
1DNA receptor (receptor, DNA)IBA
04/2015
1Platelet-Derived Growth FactorIBA
02/2015
1Alkylating AgentsIBA
01/2015
1NucleosidesIBA
01/2015
1Guanosine Diphosphate (GDP)IBA
11/2014
1eribulinFDA Link
10/2013

Therapy/Procedure

36Therapeutics
11/2022 - 02/2002
36Drug Therapy (Chemotherapy)
11/2022 - 12/2002
17Radiotherapy
12/2019 - 12/2002
6Stem Cell Transplantation
11/2022 - 06/2003
3Salvage Therapy
01/2017 - 03/2006
3Aftercare (After-Treatment)
04/2016 - 06/2005
2Combination Drug Therapy (Combination Chemotherapy)
01/2019 - 11/2003
2Splenectomy
12/2018 - 01/2015
2Breast Implants (Breast Implant)
01/2018 - 01/2018
2Transplantation
01/2017 - 11/2014
2Induction Chemotherapy
01/2013 - 12/2002
2Autologous Transplantation
06/2005 - 06/2003
1Immunotherapy
12/2018
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
08/2018
1Salpingo-oophorectomy
01/2017
1Precision Medicine
08/2015
1Time-to-Treatment
04/2015
1Adjuvant Chemotherapy
11/2013